Karam Sammy 4
4 · ABBOTT LABORATORIES · Filed Feb 23, 2022
Insider Transaction Report
Form 4
Karam Sammy
Senior Vice President
Transactions
- Award
Option (right to buy)
2022-02-18+59,708→ 59,708 totalExercise: $117.58From: 2023-02-18Exp: 2032-02-17→ Common Shares (59,708 underlying)
Footnotes (1)
- [F1]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 19,902 on February 18, 2023, 19,903 on February 18, 2024, and 19,903 on February 18, 2025.